Persistent corneal epithelial defect (PCED) patients needed
For individuals living with unhealed eye injuries, clinical trials can be an option to explore new investigational treatments. A study is currently enrolling patients with an eye injury that has not healed after treatment (often called persistent corneal epithelial defect, or PCED). PCED can lead to significant symptoms that can impact a person’s quality of life and prevent them from doing activities they once enjoyed. Click the link below for more information.
Check eligibility
Study details
Participants must:
be 18 years or older
Have a persistent corneal epithelial defect (PCED) diagnosis for at least 7 days prior to screening
Participants must not:
Have any ocular infection in the study eye that has the PCED
Have a history of surgery as a treatment method for the PCED
If you would like to speak to someone regarding this trial, first check to see if you are initially eligible through the prescreener above. If it seems that you are eligible to take part, you will be contacted by phone so we can ask you additional questions to confirm your eligibility, and you will be able to ask any questions you may have about this clinical trial. If you are not eligible based on your responses to the prescreener, you can always contact us at patientsupport@antidote.me to discuss further.